Rivernorth Capital Management’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-250,000
| Closed | -$28.6K | – | 408 |
|
|
2024
Q4 | $28.6K | Hold |
250,000
| – | – | ﹤0.01% | 274 |
|
|
2024
Q3 | $26.1K | Hold |
250,000
| – | – | ﹤0.01% | 243 |
|
|
2024
Q2 | $25K | Hold |
250,000
| – | – | ﹤0.01% | 282 |
|
|
2024
Q1 | $35K | Hold |
250,000
| – | – | ﹤0.01% | 275 |
|
|
2023
Q4 | $35K | Hold |
250,000
| – | – | ﹤0.01% | 266 |
|
|
2023
Q3 | $57.5K | Hold |
250,000
| – | – | ﹤0.01% | 290 |
|
|
2023
Q2 | $47.5K | Buy |
+250,000
| New | +$47.5K | ﹤0.01% | 312 |
|